Both in Pharmaceuticals
Aclaris Therapeutics vs DiaMedica Therapeutics
Over the past year ACRS returned +60.5% and DMAC returned +44.0%; their daily moves had a correlation of 0.19.
ACRS +60.5% DMAC +44.0%Growth of $1, one year, split-adjusted
| Metric | ACRS | DMAC |
|---|---|---|
| Price | $3.76 | $9.91 |
| Market cap | $552.7M | $534.4M |
| Today | −0.92% | +14.04% |
| 1 month | −28.9% | +20.9% |
| 6 months | −16.0% | +66.3% |
| Year to date | +24.8% | +24.5% |
| 1 year | +60.5% | +44.0% |
| Revenue growth (YoY) | −8.3% | — |
| Gross margin | 86.6% | — |
| Net margin | −1320.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 67.3× | — |
| Net cash | $91.6M | $43.5M |
| Dividend yield | — | — |
| Volatility (60d) | 76.4% | 53.1% |
| Short % of float | 12.4% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).